Clinical Trial Update: Dexmedetomidine Hydrochloride in the Prevention of Organ Failure Following Severe Acute Pancreatitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dexmedetomidine hydrochloride for prevention of organ failure in severe acute pancreatitis; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis
• Pancreatitis Acute Necrotizing

Drugs mentioned

• DEXMEDETOMIDINE HYDROCHLORIDE (Dexmedetomidine hydrochloride)

Snippet

Sponsor: Nanjing University School of Medicine | Conditions: Pancreatitis, Acute Necrotizing | Phase 4 | Status: UNKNOWN